Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Impact of Donor and Patient CMV Serology for malignant

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Lymphoïde Chronique (LLC)

Autres tumeurs malignes myéloïdes ou lymphoïdes

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Elif Ince (Ankara)

Impact of the acute GVH on outcomes in ALL

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giovanna Lucchini (London)

Evaluating the Impact of ABO Compatibility on Allogeneic Stem Cell Transplantation Outcomes

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Survey on the use of DLI after allogeneic after allogeneic stem cell transplantation across EBMT centers

Toutes les maladies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Injection de lymphocyte de donneur (DLI)

Investigateur principal

Outcome of transplant in PNH patients treated after 2011

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Transplant outcomes in patients over 40 years old with severe aplastic anemia (SAA) treated after 2010

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Antonio Risitano

Résultats de la greffe chez les patients atteints d'aplasie médullaire sévère (SAA) âgés de plus de 40 ans et traités après 2010

Études rétrospectives

Aplasie Médullaire

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Antonio Risitano

Allogeneic Hematopoietic Stem Cell Transplantation for ERCC6L2 disease

Closed Survey/Study

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Ulla Wartiovaara-Kautto, Outi Kilpivaara and Flore Sicre de Fontbrune

Allogeneic HSCT in ICU setting

Closed Survey/Study

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Tayfun Güngör

Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone: A Retrospective Study on Behalf of the CTIWP

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Myéloïde Aiguë (LMA)

Chronic Lymphocytic Leukaemia (CLL)

Leucémie Lymphoïde Chronique (LLC)

Chronic Lymphocytic Leukaemia (CLL)

Syndrome Myélodysplasique (MDS) ou MDS/MPN

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Allogénique - Haplo-identique

Investigateur principal

Impact of body mass index on outcome of CART cell therapy

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Christian Schultze-Florey

Efficacy and outcomes of allogeneic hematopoietic stem cell boost in adult patients with poor graft function

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Tatiana Rudakova